Reports: Pfizer in talks to buy Wyeth

NEW YORK - Pfizer Inc., the world's largest drugmaker, may be seeking to buy rival Wyeth in a deal that could be valued at more than $60 billion. The move would bolster Pfizer's array of products and help the company deal with expiring patents and diminishing returns on research.

Contact Us